FP7Индивидуална стипендия2012–2014

POWORMAD · A Powerful Enantioselective Organocatalytic Approach to the Total Synthesis ofMadangamine Alkaloids

7РП — „Хора“ (Действия „Мария Кюри“)

Период
2012-03-01 → 2014-02-28
Финансиране от ЕС
200 372 €
Участници
1
Схема
MC-IEF

Линиите свързват координатора с партньорите.

Накратко на български

Синтезът на алкалоидите от групата на мадангамин, като например мадангамин D, се опитва да създаде тези сложни молекули в лаборатория. Това помага за разбирането на химичните процеси, необходими за изграждане на специфични органични структури.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

A Powerful Enantioselective Organocatalytic Approach to the Total Synthesis of Madangamine Alkaloids

Our proposal is based on the development of the first successful total synthesis of a madangamine alkaloid. We believe that Madangamine D will be an excellent first target, because this saturated macrocycle offers several synthetic possibilities. Our retrosynthetic plan devised for the synthesis of the AC azabicyclic core of the madangamine alkaloids was based on the key nitro olefin Michael addition and nitro-Mannich lactamization steps to give the right diastereomer rac 2. The synthesis has been performed starting from the racemic nitroolefin 1. Reduction and tosylation of rac 2 led to compound 4 in good yield over 2 steps, and the following oxidation smoothly produced the aldehyde 5. In order to obtain the macrocycle D necessary for the synthesis of the Madangamine D, an allylic group was introduced on the aldehyde 5, followed by RCM employing 10 mol % of Grubbs Hoveyda 2nd generation catalyst to give the ACD tricycle 7. The use of 10 mol % of catalyst was possible only carrying out the reaction at low pressure (16 mbar). Tetracycle 10 has been achieved in three steps: acetal group on compound 8 was converted into tiocarbonate 9, followed by cyclisation to give 10. Subsequently the nosyl and nitro group on compound 10 were removed, and hydrogenation of the double bond on 12 led to the advanced amino alcohol 13. In order to achieve the last cyclisation to Madangamine D, the appropriate fragment 14 was synthesized. Unfortunately any attempts to coupling the iodide 14 with the tetracycle 13 resulted in very low yields of 15 (about 10 %). Other coupling reactions, which were carried out by changing the iodide group of 19 to aldehyde or carboxylic acid, produced no reaction or only trace of the desired product. PROSPECTIVES We prospect that, at this stage, only few steps divide Madangamine D from the compound 15. The last key step will be the intramolecular Julia-Kocienski to give the compound 17 (the carbonyl group on the six membered ring is plausibly more accessible), and the other carbonyl group can be removed via tiocompound 18, allowing to achieve the first total synthesis of a member of the madangamines family.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

The projet concerns the development of a powerful first total synthesis of the Madagamine alkaloids. The route starts with an organocatalytic enantioselective and diastereoselective Michael addition of cyanoacetate pronucleophiles to a nitrocyclohexene derivative, as a key step to the formation of the ABC core. When the product of this reaction is subjected to a nitro-Mannich, Mannich reaction cascade this should allow us to construct the core of the madangamine alkaloids rapidly, selectively and on scale. The overall synthetic strategy has two parts. The first concerns a fast and enantioselective assembly of diazatricyclic core common to all madangamines (ABC rings). The second concerns easy and efficient ways to build the two macrocyclic rings (D and E rings), which play a fundamental role in their biological activity. The project combines, catalysis, total synthesis, structure elucidation and evaluation of biological properties.""

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз